Michael Steinberg: PSMA-Targeted Radioligand Therapy Plus SBRT Reduces Progression Risk by 62%
Oncodaily14 Oct · 04:08← All topics · now
Development ↘
Development ↘
Development ↘
Development ↘
Development ↘
Asia Research News |14 Oct · 01:58
Development ↘
Right now
A prostate-cancer treatment combining Lu-177 PNT2002 with SBRT is extending disease control.
284 reports · the last 7 days
Summary · from headlines6 points
- PRV111 cleared early-stage oral cancer in 95.5% of patients in Phase 2.
- NIH backed a $13.1 million effort to attack breast cancer with engineered Salmonella.
- A randomized trial found targeting individual metastases in oligometastatic breast cancer failed to improve survival or extend PFS.
- NIH plans to launch a cancer vaccine initiative.
- Bowel cancer “melted away” after immunotherapy, then stayed away.
- A new clinical trial combines histotripsy with immunotherapy to treat intrahepatic bile duct cancer.
Latest developments6 to read first
Targeted radioactive therapy may help delay spread of recurrent prostate cancer, UCLA study suggests
UCLA Health14 Oct · 04:08Lu-177 PNT2002 before SBRT extends disease control in prostate cancer
AuntMinnie14 Oct · 04:08Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression
Nature14 Oct · 02:58Single-cell analysis reveals how pancreatic cancer evades treatment
News-Medical14 Oct · 01:28Timeline 284 reports
14 Oct 202612 reportsToday
04:003 reports
03:00nothing heard
02:001 report
01:003 reports
00:005 reports
13 Oct 202632 reports
23:007 reports
22:003 reports
21:00nothing heard
20:00nothing heard
19:00nothing heard
18:003 reports
17:002 reports
16:00nothing heard
15:001 report
14:00nothing heard
13:00nothing heard
12:002 reports
11:00nothing heard
10:00nothing heard
09:00nothing heard
08:00nothing heard
07:001 report
06:001 report
05:001 report
04:004 reports
03:006 reports
02:001 report
12 Oct 202618 reports
23:002 reports
22:00nothing heard
21:00nothing heard
20:003 reports
19:00nothing heard
18:003 reports
17:002 reports
16:001 report
15:00nothing heard
14:001 report
13:002 reports
12:00nothing heard
11:00nothing heard
10:001 report
09:00nothing heard
08:00nothing heard
07:001 report
06:00nothing heard
05:00nothing heard
04:00nothing heard
03:002 reports
11 Oct 202646 reports
22:003 reports
21:00nothing heard
20:001 report
19:0011 reports
18:00nothing heard
17:00nothing heard
16:00nothing heard
15:00nothing heard
14:00nothing heard
13:002 reports
12:001 report
11:001 report
10:00nothing heard
09:00nothing heard
08:003 reports
07:00nothing heard
06:007 reports
05:00nothing heard
04:00nothing heard
03:002 reports
02:006 reports
01:001 report
00:008 reports
10 Oct 202628 reports
23:002 reports
22:002 reports
21:00nothing heard
20:002 reports
19:001 report
18:007 reports
17:00nothing heard
16:00nothing heard
15:00nothing heard
14:00nothing heard
13:001 report
12:00nothing heard
11:00nothing heard
10:00nothing heard
09:002 reports
08:00nothing heard
07:00nothing heard
06:00nothing heard
05:00nothing heard
04:003 reports
03:001 report
02:003 reports
01:003 reports
00:001 report
9 Oct 202684 reports
23:007 reports
22:002 reports
21:005 reports
20:001 report
19:0010 reports
18:006 reports
17:001 report
16:001 report
15:00nothing heard
14:00nothing heard
13:002 reports
12:001 report
11:006 reports
10:003 reports
09:001 report
08:00nothing heard
07:009 reports
06:005 reports
05:001 report
04:001 report
03:008 reports
02:009 reports
01:004 reports
00:001 report
8 Oct 202664 reports
23:001 report
22:002 reports
21:00nothing heard
20:004 reports
19:003 reports
18:002 reports
17:00nothing heard
16:00nothing heard
15:003 reports
14:001 report
13:002 reports
12:002 reports
11:00nothing heard
10:001 report
09:00nothing heard
08:001 report
07:003 reports
06:005 reports
05:002 reports
04:005 reports
03:003 reports
02:007 reports
01:002 reports
00:0015 reports
← All topics · nowOne topic